Read more...Ethypharm announces the commercial launch in the US of a new product using its Flashtab® technology. Tramadol Flashtab® is available since end of May, 2010. This new commercial launch confirms Ethypharm’s strong commitment to increase its presence on the North American market.
News and Press Release
July 2010 – Ethypharm launches a new product on the US market
April 2010 – Joint Press Release : Colorcon Acquires NP Pharm
Read more...Colorcon, Inc. today announced the acquisition of the full-service pharmaceutical excipient company, NP Pharm, a Division of Ethypharm. This acquisition expands Colorcon’s global excipient product offerings in the pharmaceutical and nutritional markets.
April 2010 – Ethypharm sells its subsidiary NP Pharm
Read more...Ethypharm announces the cession of its subsidiary NP PHARM to COLORCON, a company dedicated to the development, supply and technical support of formulated coatings and excipients for the pharmaceutical industry.
April 2010 – Ethypharm moves R&D activities from Canada to France
Read more...Ethypharm announces the cession of its R&D center in Laval (Montreal), Canada. The R&D center of Laval, certified by both Canadian and American Health Authorities, was dedicated to the development of oral modified release form medicines and employed 31 people.
